Published in J Interferon Cytokine Res on January 01, 1996
Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS Pathog (2009) 1.92
All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology (2001) 1.02
Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model. PLoS One (2010) 0.87
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS One (2014) 0.87
Replication of semliki forest virus: three forms of viral RNA produced during infection. Proc Natl Acad Sci U S A (1966) 3.23
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Problems of AIDS in developing countries. J Indian Med Assoc (1992) 2.01
Inhibition of tumor growth by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.00
Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol (1987) 1.89
Recombinant human gamma interferon inhibits simian malaria. Infect Immun (1986) 1.71
Molecular basis of the action of interferon. J Mol Biol (1968) 1.70
Thymosin beta4 accelerates wound healing. J Invest Dermatol (1999) 1.50
Sterile protection of monkeys against malaria after administration of interleukin-12. Nat Med (1997) 1.48
Acceleration of viral replication and up-regulation of cytokine levels by antimalarials: implications in malaria-endemic areas. Am J Trop Med Hyg (1999) 1.45
Interferon preparations as modifiers of immune responses. Proc Soc Exp Biol Med (1972) 1.44
Ribosomes: effect of interferon on their interaction with rapidly labeled cellular and viral RNA's. Science (1967) 1.44
The recognition of viral RNA by mammalian ribosomes. An effect of interferon. Biochim Biophys Acta (1968) 1.44
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst (1976) 1.42
Inhibition of biologic activity of poly I: poly C by human plasma. Proc Soc Exp Biol Med (1970) 1.42
Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen (1999) 1.40
Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery (1996) 1.39
Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei. Indian J Med Res (1979) 1.37
Enhancement of wound healing by curcumin in animals. Wound Repair Regen (1999) 1.34
Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine. J Infect Dis (1977) 1.33
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
Effect of interferon on early interferon production. Science (1966) 1.30
Interferon action on parental Semliki forest virus ribonucleic acid. J Virol (1967) 1.28
Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis (1977) 1.19
An interdisciplinary method of classifying and monitoring medication errors. Am J Hosp Pharm (1985) 1.19
The effect of polyinosinic-polycytidylic acid upon graft-vs-host activity in BALB/c mice. J Immunol (1970) 1.18
Interferon and uninfected cells. Proc Soc Exp Biol Med (1966) 1.15
How healthy is our national health policy? J Indian Med Assoc (1988) 1.12
Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer. Lancet (1976) 1.10
Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ (1998) 1.10
Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J Virol (1992) 1.09
Interferon: lack of detectable uptake by cells. Science (1966) 1.09
Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant. Infect Immun (1976) 1.09
Interferon and interferon inducers in the treatment of malignancies. Arch Intern Med (1970) 1.08
Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys. J Infect Dis (1979) 1.07
Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans. Infect Immun (1979) 1.05
Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrob Agents Chemother (1995) 1.04
Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys. Science (1977) 1.03
Lack of correlation between interferon induction and antitumour effect of poly I-poly C. Nat New Biol (1971) 1.02
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex. Antimicrob Agents Chemother (1977) 1.01
Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. Cancer Res (1979) 1.01
Phase I-II trials of poly IC stabilized with poly-L-lysine. Cancer Treat Rep (1978) 1.00
Quinoline esters as potential antimalarial drugs: effect on relapses of Plasmodium cynomolgi infections in monkeys. Trans R Soc Trop Med Hyg (1991) 0.99
Child labor. Indian Pediatr (1986) 0.99
A preliminary trial of poly(I,C)-LC in multiple sclerosis. J Biol Response Mod (1985) 0.99
Postinfectious encephalopathy after treatment of herpes simplex encephalitis with acyclovir. Pediatr Infect Dis (1984) 0.99
Interferon treatment inhibits glycosylation of a viral protein. Nature (1980) 0.97
The effect of interferon, interferon inducers or interferon induced virus resistance on subsequent interferon production. J Gen Virol (1972) 0.97
Involvement of malarial proteases in the interaction between the parasite and host erythrocyte in Plasmodium knowlesi infections. J Parasitol (1981) 0.97
Induction of interferon in lymphoblastoid cell lines. Proc Soc Exp Biol Med (1970) 0.96
Plasmodium falciparum: drug-resistant malaria complicating leukemias and lymphomas in children. Exp Parasitol (1999) 0.95
Interferon. Annu Rev Microbiol (1966) 0.95
Mefloquine resistance reversal action of ketoconazole - a cytochrome P450 inhibitor, against mefloquine-resistant malaria. Parasitology (2005) 0.95
Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA). Anticancer Res (2000) 0.94
Mechanisms of DEAE-dextran enhancement of polynucleotide induction of interferon. Proc Soc Exp Biol Med (1971) 0.94
Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett (1996) 0.94
Prophylactic control of simian hemorrhagic fever in monkeys by an interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine. J Infect Dis (1976) 0.91
Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data. Proc Natl Acad Sci U S A (1980) 0.90
Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury. Eur J Pharmacol (2000) 0.90
Studies on poly I:C toxicity in experimental animals. Toxicol Appl Pharmacol (1972) 0.90
Effect of interferon on togavirus and arenavirus infections of animals. Tex Rep Biol Med (1977) 0.89
Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells. Science (1980) 0.89
Arnebin-1 accelerates normal and hydrocortisone-induced impaired wound healing. J Invest Dermatol (1999) 0.89
Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity. Virology (1980) 0.89
The effect of polyinosinic:polycytidylic acid on tumor metabolism. Proc Soc Exp Biol Med (1970) 0.89
Polyinosinic-polycytidylic acid inhibits chemically induced tumorigenesis in mouse skin. Science (1970) 0.88
Prevention of renal ischemia-reperfusion-induced injury in rats by picroliv. Biochem Pharmacol (2000) 0.88
Dactinomycin: relative resistance of green monkey kidney cell cultures to its action. Proc Soc Exp Biol Med (1967) 0.88
Enhanced wound healing in animal models by interferon and an interferon inducer. J Cell Physiol (1992) 0.87
An intracellular simian malarial parasite (Plasmodium knowlesi) induces stage-dependent alterations in membrane phospholipid organization of its host erythrocyte. Biochem J (1987) 0.87
Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer. Am J Trop Med Hyg (1995) 0.87
Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol (1998) 0.87
Effect of interferon on RNA synthesis in Sindbis virus infected cells. Proc Soc Exp Biol Med (1966) 0.86
Epstein-Barr virus and Herpesvirus saimiri: sensitivity to interferons and interferon inducers. J Natl Cancer Inst (1981) 0.86
Topical treatment of vaccinia virus infection with an interferon inducer in rabbits. J Infect Dis (1978) 0.86
Interferon alters intracellular transport of vesicular stomatitis virus glycoprotein. J Biol Regul Homeost Agents (1988) 0.86
Immunoprophylactic strategies against respiratory influenza virus infection. Vaccine (2001) 0.85
Effect of interferon treatment on cellular messenger RNA. Proc Natl Acad Sci U S A (1973) 0.85
Protein synthesis by amoebal ribosomes. Nature (1967) 0.85
Factors inducing excystation in free-living amoebae. Indian J Exp Biol (1971) 0.85
Possibility of scrub typhus in fever of unknown origin (FUO) cases: an experience from Rajasthan. Indian J Med Microbiol (2014) 0.84
Antibiotics in the chemotherapy of malaria. Prog Drug Res (1982) 0.84
Virulence of strains of Entamoeba histolytica to rats and the effect of cholesterol, rat caecal and hamster liver passage on the virulence of non-invasive strains. Indian J Exp Biol (1971) 0.84
Induction of interferon by preparations of synthetic single-stranded RNA. Proc Natl Acad Sci U S A (1969) 0.84
Historical overview of the use of polynucleotides in cancer. J Biol Response Mod (1985) 0.83
An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine. Bull World Health Organ (1979) 0.83
Enhancement of wound healing by shikonin analogue 93/637 in normal and impaired healing. Skin Pharmacol Physiol (2004) 0.83
Causal prophylactic activity of a new 8-aminoquinoline derivative against Plasmodium cynomolgi B in rhesus monkeys. Indian J Med Res (1990) 0.83
Assay of effect of interferon on viruses that bud from plasma membrane. Methods Enzymol (1981) 0.83
Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man. Tex Rep Biol Med (1983) 0.83
Mechanism of interferon inhibition of viruses that bud from the plasma membrane. Ann N Y Acad Sci (1980) 0.83
Immunomodulation by morphine in Plasmodium berghei-infected mice. Life Sci (1994) 0.82
Induction of interferon in vivo and in vitro by polynucleotides and derivatives, and preparation of derivatives. Methods Enzymol (1981) 0.82
Production of vesicular stomatitis virus with low infectivity by interferon-treated cells. J Gen Virol (1979) 0.82
Immunochemotherapy for Leishmania donovani infection in golden hamsters: combinatorial action of poly ICLC plus L-arginine and sodium stibogluconate (Stibanate). J Interferon Cytokine Res (1999) 0.82
Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size. Infect Immun (1981) 0.82
A new look at nonparasitized red cells of malaria-infected monkeys. Nature (1982) 0.82
Chlorite-oxidized amylose as an adjuvant for interferon production. Infect Immun (1973) 0.82